IBM’s quantum-computing strategy now has a date attached to it. CEO Arvind Krishna said the company’s investments in the technology should have a measurable impact on revenue and earnings by 2028 or 2029, creating a medium-term benchmark for one of the company’s most ambitious research initiatives.

That timeline does not make quantum computing an immediate earnings driver. It does, however, give investors and analysts a defined period in which to assess whether IBM can move from technical development toward products, customers and financial contribution. As reported in CNBC on July 30, 2026, Krishna’s remarks frame quantum computing as a potential commercial catalyst rather than solely a long-duration research program.

A deadline for commercialization

For IBM ($IBM), the importance of the 2028–2029 window is its measurability. Quantum computing has attracted substantial interest as a possible next-generation technology, but research progress alone does not establish a revenue stream or improve earnings. Krishna’s comments set a point at which those broader ambitions should begin showing up in the company’s financial performance.

The benchmark gives the market several questions to track:

• Whether IBM can convert quantum-computing development into commercial products or services.
• Whether customer adoption develops sufficiently to support revenue contribution.
• Whether that contribution becomes visible in earnings by 2028 or 2029.

Those questions are more useful than treating quantum computing as an immediate financial driver. The stated impact remains forward-looking, and the assignment contains no revenue figure, earnings estimate or valuation measure for the quantum business. The central issue is therefore execution against the timetable, not a near-term change to IBM’s reported results.

Why the timeline matters to investors

A specific target can improve accountability. Investors and analysts may use the 2028–2029 period to compare IBM’s product development and commercialization progress with management’s stated objective. Evidence of advancing offerings, customer activity and financial contribution could support the view that the company is turning long-term research investment into a business opportunity.

Conversely, a lack of measurable revenue or earnings impact by that window could raise questions about the pace of commercialization. The benchmark does not eliminate technological or execution uncertainty. It simply establishes a timeframe against which those uncertainties may be judged.

Growth appeal, with a long runway

For growth-oriented investors, quantum computing may add a longer-term dimension to the IBM story. Krishna’s remarks suggest that management sees the technology as capable of contributing to both revenue and earnings, rather than treating it as an isolated scientific project with no defined commercial endpoint.

But the distinction between potential and performance is critical. IBM has not presented quantum computing in these comments as an immediate earnings contributor. The expected impact is several years away, and the outcome depends on development, commercialization and customer adoption progressing sufficiently.

That makes 2028–2029 a useful monitoring horizon, not a present-day financial conclusion. Until measurable results emerge, quantum computing remains a forward-looking part of IBM’s strategy. The market may reward evidence of progress, but the most important data point will be whether that progress ultimately reaches revenue and earnings.